Your search for "Press release" return 97 results.
Ceva develops Vectormune© HVT AIV vaccine to combat Avian Influenza >
USDA approval announced at 8th International Symposium on Avian Influenza
New commercial licenses for viral vaccine production >
Ceva takes commercial license for ProBioGen’s AGE1.CR® Cell Line for viral vaccine production
Product Acquisition in Australia >
Ceva acquires a number of Parnell products in move to further strengthen its Australian business
Ceva continues rapid growth in 2011 >
Twin pillar strategy of combining internal and external growth opportunities drives further global expansion
Ceva organizes Gumboro Symposium in Budapest >
Innovation in poultry health will be driven by combining the latest biotechnology solutions with improved hatchery application and services.
Transmune.com goes online ! >
CEVAC TRANSMUNE, the innovative vaccine for the control of Gumboro Disease, used in more than 50 countries is now online on Transmune.com !!
Ceva Workshop at the European Buiatrics Forum >
Challenges in cattle reproduction was the focus of a workshop organized by Ceva Santé Animale as part of the European Buiatrics Forum which took place in November in the French city of Marseilles.
Second joint Human and Veterinary Cardiology Symposium >
Together for health, in the heart of Bordeaux
Ceva acquires CentaurVA Animal Health >
Company continues to expand its North American operations with entry into Canada.
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio